Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists launch world’s first antimicrobial medical gloves
Researchers expect the gloves to eventually sell in their billions, as healthcare providers battle to fight infection and combat antimicrobial resistance.
Gloves a "game changer" for the healthcare industry

The world’s first non-leaching antimicrobial gloves were launched yesterday (31 May) in London.

The gloves contain a new active microorganism-killing molecule designed to prevent the spread of bacteria. Because the technology is built into the material, the gloves don’t need surface applications of further solutions or testing.

In independent testing, the gloves achieved a 99.9 per cent kill within just five minutes of contact. University of Nottingham microbiologist Richard James, who helped with the project, said the gloves will be a “game-changer” for the healthcare industry.

“I am delighted that my lifetime’s research into bacteria and antibiotic resistance has directly informed the science behind a practical tool that will have a major impact on medical care in the future,” he said.

The gloves are the culmination of more than six years of research by Professor James, medical glove makers Hartalega Malaysia and development company Chemical Intelligence UK. They are expected to sell in their billions, as healthcare providers battle to fight infection and combat antimicrobial resistance.

“In the European Union alone, cross-contamination in hospitals results in 37,000 deaths a year at an additional cost of 7 billion euros,” said Mr Kuan Mun Leong, managing director of Hartalega Holdings. “By renovating a medical device that has not been remodelled in over 30 years, our innovation is set to make waves in the healthcare industry and save lives across the globe.”

Chemical Intelligence UK founder Rob Gross added: “After years of development, we are delighted to finally release this product to market and truly believe it will make a significant difference in the fight against healthcare-associated infections (HAIs). Like Hartalega, we have a passion for innovation and together we are the perfect partners to release this technology.”

Become a member or log in to add this story to your CPD history

Report: A third of Welsh birds are in decline

News Story 1
 A report by RSPB Cymru and partnering ornithology organisations has revealed that a third of bird species in Wales are in significant decline.

90 per cent of Wales is farmed and there is now pressure to implement new land management policies that will aid in nature restoration.

Patrick Lindley, Maritime Ornithologist for Natural Resources Wales, commented: “The problems that confront UK birds, whether they are breeding or non-breeding, are pressure and threats that confront entire ecosystems.

“Birds are a great indicator to the health of our environment. The continued population declines of birds of farmed, woodland and upland habitats suggest there are large geographic themes that are having a detrimental impact.”  

Click here for more...
News Shorts
BSAVA announces winner of 2019 Bourgelat Award

One of the world’s leading small animal medicine specialists is set to receive the prestigious Bourgelat Award at BSAVA Congress 2019.

Professor Mike Herrtage will be recognised for his major research into metabolic and endocrine diseases, including diabetes mellitus, Cushing’s disease and Addison’s disease.

During his career, Prof Herrtage has co-authored more than 100 scientific papers and written more than 200 other publications such as abstracts, books and chapters. He also continues to be a source of inspiration for thousands of undergraduate and postgraduate veterinary surgeons.